Moreover, the pharmacological effects of cisplatin (DDP), a chemotherapy agent used to inhibit tumor growth in vivo, are reduced by the overexpression of BRD4, suggesting that BRD4 could serve as a novel therapeutic target for bladder cancer.57 The gene discussed is BRD4; the disease is urinary bladder carcinoma.